Table 2.
Measures | Target population(s) | For primary/secondary nonadherence | Advantages | Disadvantages |
---|---|---|---|---|
Direct measures | Patients under single-dose therapy and intermittent administration and who are hospitalized | Both primary and secondary nonadherence | Most accurate Can provide physical evidence |
Generate a Yes/No result only Intrusive Varied drug metabolism Nonquantifiable biomarkers/drug metabolites Drug-drug interactions and drug-food interactions Expensive Require qualified staff and techniques to perform Bias occurs if patients know the schedule of the tests (white coat adherence) |
| ||||
Measures involving secondary database analysis | Countries that allow refilling prescription; with centralized computerized system with a consistency among prescribers and dispensers; more common for research with a large population |
Primary nonadherence | Able to assess multidrug adherence Can identify patients at risk for treatment failure Provide medication-refilling pattern Complete dataset used are generally verified by a third party for insurance claim purpose |
Assumptions are made (the medication-taking behavior corresponds to prescription refilling and the medications are taken according to prescription) Fail to identify partial adherence Fail to identify barriers for the detected nonadherence Missing out prescriptions, if obtained outside the system Incomplete records, if drug discontinuation is verbally advised by prescriber |
| ||||
Measures involving Electronic Medication Packaging (EMP) devices | Studies with small population As reference standard to validate other measures |
Secondary nonadherence | Highly accurate Identify medication-taking pattern Identify partial adherence |
Expensive Technical supports required Overestimation if patients accidently or purposefully actuate the container Inconvenience due to bulky container Pressure to patients |
| ||||
Pill count | Routine clinical practice | Primary nonadherence | Low cost Simple Can be used in various formulations Highly accurate |
Not for nondiscrete dosages or prn medications Underestimation due to early refill Arbitrary cutoff value Unable to identify medication-taking pattern |
| ||||
Measures involving clinician assessments and self-report | Routine clinical practice Less suitable for research |
It depends on the type of assessments and questionnaires used | Low cost Easy to administer Real-time feedback Available Flexible to accommodate different conditions Identify belief and barriers to adherence Well-validated |
Least reliable Relatively poor sensitivity and specificity Affected by communication skills of interviewers and questions in the questionnaire Patient's desirability can bias |